14.08.2013 15:31:00
|
Critical Alerts For Facebook, Orbitz, Eli Lilly, Dominion Resources, and Endo Pharmaceuticals Released By InvestorsObserver
CHICAGO, Aug. 14, 2013 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FB, OWW, LLY, D, and ENDP.
To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at http://www.investorsobserver.com/pr/81320130 (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover the following stocks: Facebook (Nasdaq: FB), Orbitz (NYSE: OWW), Eli Lilly (NYSE: LLY), Dominion Resources (NYSE: D), and Endo Pharmaceuticals (Nasdaq: ENDP).
InvestorsObserver's PriceWatch Alerts contain concise, detailed strategies for each stock we cover, including position protection tactics designed to defend investors from potential market shifts. While many other market reports only provide stock news and opinion, we offer strategies that can bulwark investments against uncertainty and increase chances of making a profit, even if a stock goes down.
"We go above and beyond typical market coverage," said Bobby Raines, Analyst at InvestorsObserver. "Trading experts and beginning investors alike can find value in our PriceWatch Alerts. We provide actionable strategies that protect investments with basic hedging tactics, along with a concise explanation of our techniques."
For essential information on stocks poised to move go to:
http://www.investorsobserver.com/pr/81320130 for InvestorsObserver's PriceWatch Alerts.
InvestorsObserver.com is an online newsletter which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help subscribers make the best possible investment decisions. For more information go to www.investorsobserver.com.
All stocks and options shown are examples only—not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes—expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available at http://www.cboe.com/Resources/Intro.aspx. Privacy policy available upon request.
SOURCE InvestorsObserver
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
26.11.24 |
Handel in New York: S&P 500 letztendlich im Aufwind (finanzen.at) | |
26.11.24 |
Optimismus in New York: So entwickelt sich der S&P 500 am Nachmittag (finanzen.at) | |
26.11.24 |
Börse New York in Grün: S&P 500 im Plus (finanzen.at) | |
26.11.24 |
S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Eli Lilly-Investment von vor 5 Jahren abgeworfen (finanzen.at) | |
26.11.24 |
Börse New York: S&P 500 präsentiert sich zum Start fester (finanzen.at) | |
19.11.24 |
S&P 500-Wert Eli Lilly-Aktie: So viel Gewinn hätte eine Eli Lilly-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
18.11.24 |
Börse New York: S&P 500 verbucht am Nachmittag Gewinne (finanzen.at) | |
18.11.24 |
Börse New York: mittags Gewinne im S&P 500 (finanzen.at) |
Analysen zu Eli Lillymehr Analysen
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Dominion Energy Inc. | 55,64 | -1,49% | |
Eli Lilly | 747,90 | 0,36% | |
Meta Platforms (ex Facebook) | 544,10 | 0,68% |